Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.

2026-07-04 04:22:00 ET Biogen (NASDAQ: BIIB) built itself into a biotech giant thanks to its port